2013
DOI: 10.1134/s1068162013060101
|View full text |Cite
|
Sign up to set email alerts
|

Immunoassay of nine serological tumor markers on a hydrogel-based microchip

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Detection of tumor markers AFP, HCG, CEA, CA 19–9, CA 125, and CA 15–3 in serum samples was performed on protein biochip by immunofluorescence analysis as described earlier . The study of 33 samples from the patients with CRC revealed increased concentration of CEA in 17% of patients, CA 19–9 in 13%, CA 125 in 17%, and CA 15–3 in 13%.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Detection of tumor markers AFP, HCG, CEA, CA 19–9, CA 125, and CA 15–3 in serum samples was performed on protein biochip by immunofluorescence analysis as described earlier . The study of 33 samples from the patients with CRC revealed increased concentration of CEA in 17% of patients, CA 19–9 in 13%, CA 125 in 17%, and CA 15–3 in 13%.…”
Section: Resultsmentioning
confidence: 99%
“…Here, we detected the levels of antibodies to glycans SiaTn, TF, Tn, Le C , Le Y , SiaLe A , and Man β 1‐4GlcNAc β as well as the level of the immunoglobulins IgG, IgA, and IgM using glycochip. Concentrations of protein cancer markers CEA, CA 19–9, CA 125, CA 15–3, HCG, and AFP were determined by immunofluorescence analysis using a protein biochip diagnostic test system . The 3D hydrogel biochips were manufactured using previously described technology that yields gel cells of uniform size and distribution of the probes within the cells, which is necessary for quantitative analysis.…”
Section: Introductionmentioning
confidence: 99%